These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 18519784

  • 1. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma.
    Araki K, Ahmad SM, Li G, Bray DA, Saito K, Wang D, Wirtz U, Sreedharan S, O'Malley BW, Li D.
    Clin Cancer Res; 2008 Jun 01; 14(11):3514-9. PubMed ID: 18519784
    [Abstract] [Full Text] [Related]

  • 2. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
    Li D, Day KV, Yu S, Shi G, Liu S, Guo M, Xu Y, Sreedharan S, O'Malley BW.
    Cancer Res; 2002 Aug 15; 62(16):4637-44. PubMed ID: 12183420
    [Abstract] [Full Text] [Related]

  • 3. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer.
    Tran HM, Shi G, Li G, Carney JP, O'Malley B, Li D.
    Otolaryngol Head Neck Surg; 2004 Oct 15; 131(4):477-84. PubMed ID: 15467621
    [Abstract] [Full Text] [Related]

  • 4. Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer.
    Bray D, Yu SZ, Koprowski H, Rhee J, Kumar S, Pericle F, Suntharalingam M, Van Echo DA, Li D, O'Malley BW.
    Arch Otolaryngol Head Neck Surg; 2003 Jun 15; 129(6):618-22. PubMed ID: 12810463
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427.
    Khan K, Araki K, Wang D, Li G, Li X, Zhang J, Xu W, Hoover RK, Lauter S, O'Malley B, Lapidus RG, Li D.
    Head Neck; 2010 Mar 15; 32(3):381-91. PubMed ID: 19672867
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T, Sun SY, Lotan R, Fujiwara T, Yasumatsu R, Komiyama S, Clayman GL.
    Laryngoscope; 2001 Aug 15; 111(8):1459-64. PubMed ID: 11568584
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
    Day KV, Li D, Liu S, Guo M, O'Malley BW.
    Laryngoscope; 2001 May 15; 111(5):801-6. PubMed ID: 11368071
    [Abstract] [Full Text] [Related]

  • 13. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
    Vink SR, Lagerwerf S, Mesman E, Schellens JH, Begg AC, van Blitterswijk WJ, Verheij M.
    Clin Cancer Res; 2006 Mar 01; 12(5):1615-22. PubMed ID: 16533789
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
    Fujita T, Timme TL, Tabata K, Naruishi K, Kusaka N, Watanabe M, Abdelfattah E, Zhu JX, Ren C, Ren C, Yang G, Goltsov A, Wang H, Vlachaki MT, Teh BS, Butler EB, Thompson TC.
    Gene Ther; 2007 Feb 01; 14(3):227-36. PubMed ID: 17024109
    [Abstract] [Full Text] [Related]

  • 16. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy.
    Pirollo KF, Hao Z, Rait A, Jang YJ, Fee WE, Ryan P, Chiang Y, Chang EH.
    Oncogene; 1997 Apr 10; 14(14):1735-46. PubMed ID: 9135075
    [Abstract] [Full Text] [Related]

  • 17. Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS).
    Gaut AW, Niu G, Krager KJ, Graham MM, Trask DK, Domann FE.
    Head Neck; 2004 Mar 10; 26(3):265-71. PubMed ID: 14999802
    [Abstract] [Full Text] [Related]

  • 18. FasL gene therapy: a new therapeutic modality for head and neck cancer.
    ElOjeimy S, McKillop JC, El-Zawahry AM, Holman DH, Liu X, Schwartz DA, Day TA, Dong JY, Norris JS.
    Cancer Gene Ther; 2006 Aug 10; 13(8):739-45. PubMed ID: 16543918
    [Abstract] [Full Text] [Related]

  • 19. eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival.
    Siegele B, Cefalu C, Holm N, Sun G, Tubbs J, Meschonat C, Odaka Y, DeBenedetti A, Ghali GE, Chu Q, Mathis JM, Li BD.
    J Surg Res; 2008 Jul 10; 148(1):83-9. PubMed ID: 18570935
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.